Press Releases

11.04.2013

JDRF Teams Up with Pfizer’s Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes

10.16.2013

Siemens enters into master agreement with Pfizer for companion diagnostics

10.09.2013

MaRS Innovation and Pfizer Fund Bio-Manufacturing Technology

09.13.2013

Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases

06.06.2013

CytomX Announces Global Strategic Collaboration with Pfizer to Develop and Commercialize Multiple Probody™-Drug Conjugates in Oncology

04.03.2013

BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins

01.03.2013

Philogen S.p.A. Announces Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases

01.03.2013

Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program

12.21.2012

Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase

12.20.2012

Humedica and Pfizer Form Strategic Alliance

11.30.2012

Pfizer Completes Sale of Nutrition Business to Nestlé

11.28.2012

Pfizer Acquires NextWave Pharmaceuticals, Inc.